A Korean Parkinson's disease family with the LRRK2 p.Tyr1699Cys mutation showing clinical heterogeneity
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Ji Sun | - |
dc.contributor.author | Cho, Jin Whan | - |
dc.contributor.author | Shin, Hyeeun | - |
dc.contributor.author | Lee, Won Yong | - |
dc.contributor.author | Ki, Chang-Seok | - |
dc.contributor.author | Cho, Ah Ra | - |
dc.contributor.author | Kim, Hee-Tae | - |
dc.date.accessioned | 2022-07-16T16:49:49Z | - |
dc.date.available | 2022-07-16T16:49:49Z | - |
dc.date.created | 2021-05-12 | - |
dc.date.issued | 2012-02 | - |
dc.identifier.issn | 0885-3185 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/166362 | - |
dc.description.abstract | Background: Although leucine-rich repeat kinase 2 (LRRK2) is the gene most commonly linked to autosomal dominant inherited Parkinson's disease (PD), there have been few reports in Asia, probably because of population-specific differences in allele frequencies. Methods: We identified a large Korean PD family with the p.Tyr1699Cys mutation in LRRK2 and analyzed genealogical, clinical, and genetic data from the family. Results: Although the clinical findings of these patients were indistinguishable from those of patients with sporadic PD, the patients with the p.Tyr1699Cys mutation demonstrated clinical heterogeneity including differences in age at onset, rate of disease progression, clinical phenotype, and prognosis. Conclusions: This is the first report describing an Asian PD family with the p.Tyr1699Cys mutation in LRRK2. The affected members of this family showed clinical heterogeneity. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | WILEY | - |
dc.title | A Korean Parkinson's disease family with the LRRK2 p.Tyr1699Cys mutation showing clinical heterogeneity | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kim, Hee-Tae | - |
dc.identifier.doi | 10.1002/mds.24033 | - |
dc.identifier.scopusid | 2-s2.0-84856968901 | - |
dc.identifier.wosid | 000300429200026 | - |
dc.identifier.bibliographicCitation | MOVEMENT DISORDERS, v.27, no.2, pp.320 - 324 | - |
dc.relation.isPartOf | MOVEMENT DISORDERS | - |
dc.citation.title | MOVEMENT DISORDERS | - |
dc.citation.volume | 27 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 320 | - |
dc.citation.endPage | 324 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Neurosciences & Neurology | - |
dc.relation.journalWebOfScienceCategory | Clinical Neurology | - |
dc.subject.keywordPlus | NONMOTOR SYMPTOMS | - |
dc.subject.keywordPlus | RISK-FACTOR | - |
dc.subject.keywordPlus | G2019S | - |
dc.subject.keywordPlus | IDENTIFICATION | - |
dc.subject.keywordPlus | GLY2385ARG | - |
dc.subject.keywordPlus | PHENOTYPE | - |
dc.subject.keywordPlus | VARIANT | - |
dc.subject.keywordPlus | CHINESE | - |
dc.subject.keywordPlus | GENE | - |
dc.subject.keywordAuthor | Parkinson&apos | - |
dc.subject.keywordAuthor | s disease | - |
dc.subject.keywordAuthor | leucine-rich repeat kinase 2 (LRRK2) | - |
dc.subject.keywordAuthor | p | - |
dc.subject.keywordAuthor | Tyr1699Cys mutation | - |
dc.subject.keywordAuthor | clinical heterogeneity | - |
dc.identifier.url | https://movementdisorders.onlinelibrary.wiley.com/doi/10.1002/mds.24033 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.